5693-S AMS RIVE S4956.2
SSB 5693 - S AMD 1223
By Senator Rivers
ADOPTED 02/25/2022
On page 235, line 9, increase the General Fund—State Appropriation (FY 2023) by $3,735,000
On page 235, line 11, increase the General Fund—Federal Appropriation by $17,810,000
Adjust the total appropriation accordingly.
On page 271, after line 19, insert the following:
"(111)(a) $3,735,000 of the general fund—state appropriation for fiscal year 2023 and $17,810,000 of the general fund—federal appropriation are provided solely for the authority to provide coverage for all federal food and drug administration-approved HIV antiviral drugs without prior authorization beginning January 1, 2023.
(b) Beginning January 1, 2023, upon initiation or renewal of a contract with the authority to administer a medicaid managed care plan, a managed health care system shall provide coverage without prior authorization for all federal food and drug administration-approved HIV antiviral drugs."
EFFECT: Requires Apple Health to cover all Food and Drug Administration-approved HIV antiviral drugs without prior authorization.
EXPENDITURE EFFECT (2021-2023): $3,735,000 Near General Fund—State/$21,545,000 Total Funds
FOUR-YEAR OUTLOOK EXPENDITURE EFFECT: $18,675,000 Near General Fund—State
--- END ---